NEW YORK (GenomeWeb News) – SAIC-Frederick today said that it is collaborating with Biomatrica on developing better processes for isolating nucleic acids from tumor samples collected by pathologists in clinics.
Under the alliance, SAIC-Frederick's researchers in its Laboratory Animal Sciences Program will explore integrating Biomatrica's reagents into molecular pathology workflows. The goal of the collaboration is to streamline processes and increase the efficiency and integrity of RNA isolated from histological samples. According to SAIC-Frederick, preserving RNA is important for correlating histology of tumor tissues and molecular analysis, but traditional methods for preserving nucleic acids are not well adapted to the clinical setting.
The collaboration was developed under the Advanced Technology Partnerships Initiative of the National Cancer Institute. SAIC-Frederick is a contractor for NCI and facilitates partnerships for the ATPI.